We would love to hear your thoughts about our site and services, please take our survey here.
Get ready for a few percentages up at the end of the day ahead of the AGM.. and the early morning sell!
The share that just keeps taking…
Unfortunately Synairgen have done exactly this in the past.
I would urge great caution in using this as any investment basis.
It’s the magic 26%.. read up on your company law.
Who is this guy called Hugh.. making huge buys?
So light it’s not true… there is no Porsche dealership in Southampton.
This is what you should take notice of.. everyone else’s speculation is .. well just irresponsible speculation.
RICHARD MARSDEN: So we get data early next year. And if the data is really good and if COVID persists as a problem, then we hope to file for an EUA. And there's precedent there from other people's programs, in terms of how long it takes from data through to submission through to availability. And that's measured in months in this pandemic, not years like it might normally be.
Is it true?
“The Board places great importance on the need for effective communication with investors and the media. To ensure that all existing and future stakeholders are able to track our progress and obtain updates as soon as available”
That’s £2.16 in real money.. nice lift in the morning.
RM pre booked for later in the week.
I would have thought that would be super sensitive information that could only be released after a more significant release on results.
Maybe some pre booked interviews are at play with an embargoed news release.
Very very interesting for you detectives types.
Hmmm… interesting RM appearing later in the week to discuss “when this will be available”.
Bit of a give away that.
Of course there is… just not on your timescales..
What will be will be.
Relax, sit back and enjoy the roller coaster that is Synairgen.
From where I’m anchored it’s going to be a beautiful day..
Good fortune everyone.
Schroeder - a takeover is far from a given - you should take a look at the license deal that BioNtech (a company just a few years old) have with Pfizer.. mutually beneficial and created a company currently valued at $84 billion and still heading north.
It’s why we are all here. I very much doubt a takeover is in the interest of any shareholder however large.
From where I’m still sitting… today’s graph is sweeter than yesterday’s… which in itself was attractive in a supply and demanding type of way..
More elegant in its sweep don’t you agree?
From where I’m sitting… todays trading graph looks refreshingly refreshing!
It’s a while since it showed anything resembling a typical schoolboy upward supply and demand curve…
Now that’s rather interesting in itself.
A persuasive video.. the radio 4 broadcast was too..
and the science is good.
Economypost.com
‘ Interestingly, analysts are already expecting that Synairgen will be granted approval for SNG001 this year and the company is forecasted to end 2021 with sales of around £146.5 million.
Moreover, sales are expected to climb to £583 million in 2022 and may continue to move higher in subsequent years if results from these trials are positive and the drug is approved for treating other conditions apart from COVID.
At its current market capitalization of £300 million, this stock does have the potential to become the next Moderna as long as the Phase III trial meets its primary endpoints’.
Well.. that’s an interesting prediction..
check out BioNtech share price this evening at $323 a share..
now that would be exciting!